Afuco™ Anti-Human CD27 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CD27 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Human antibodies immunospecific for human CD27 are capable of blocking CD27 binding to its ligand CD70 and neutralizing bioactivity of CD27. The antibodies are useful in diagnosing or treating CD27 activity associated diseases and conditions.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-110CL |
Pricing | Inquiry |
Host | Human |
Target | CD27 |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage |
|